Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
Top Cited Papers
Open Access
- 1 April 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9212), 1295-1302
- https://doi.org/10.1016/s0140-6736(00)02110-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular SurgeryNew England Journal of Medicine, 1999
- Drugs in the peri-operative period: 4 - Cardiovascular drugsDrug and Therapeutics Bulletin, 1999
- Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analysesBritish Journal of Surgery, 1997
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- PHARMACOLOGICAL THROMBOPROPHYLAXIS IN HIP AND KNEE SURGERY: A SURVEY OF NEW ZEALAND ORTHOPAEDIC SURGEONSAnz Journal of Surgery, 1994
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.BMJ, 1992
- Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisThe Lancet, 1992
- Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young menThe American Journal of Cardiology, 1992
- Deep venous thrombosis: a continuing problem.BMJ, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988